Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort

Authors

Maartje I. Kester, VU University Medical Center
Charlotte E. Teunissen, VU University Medical Center
Courtney Sutphen, Washington University School of Medicine in St. Louis
Elizabeth M. Herries, Washington University School of Medicine in St. Louis
Jack H. Ladenson, Washington University School of Medicine in St. Louis
Chengjie Xiong, Washington University School of Medicine in St. Louis
Philip Sheltens, VU University Medical Center
Wiesje M. van der Flier, VU University Medical Center
John C. Morris, Washington University School of Medicine in St. Louis
David M. Holtzman, Washington University School of Medicine in St. LouisFollow
Anne M. Fagan, Washington University School of Medicine in St. LouisFollow

Journal

Alzheimer's Research & Therapy

Publication Date

2015

Volume

7

Inclusive Pages

59

Document Type

Open Access Publication

DOI

10.1186/s13195-015-0142-1

Rights and Permissions

Kester et al. Alzheimer's Research & Therapy (2015) 7:59 DOI 10.1186/s13195-015-0142-1

Recommended Citation

Kester, Maartje I.; Teunissen, Charlotte E.; Sutphen, Courtney; Herries, Elizabeth M.; Ladenson, Jack H.; Xiong, Chengjie; Sheltens, Philip; van der Flier, Wiesje M.; Morris, John C.; Holtzman, David M.; and Fagan, Anne M., "Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort." Alzheimer's Research & Therapy. 7, 59. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4264